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Abstract
SNP-heritability is a fundamental quantity in the study of complex traits. Recent works have 
shown that existing methods to estimate genome-wide SNP-heritability yield biases when their 
assumptions are violated. While various approaches have been proposed to account for frequency- 
and LD-dependent genetic architectures, it remains unclear which estimates reported in the 
literature are reliable. Here we show that genome-wide SNP-heritability can be accurately 
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estimated from biobank-scale data irrespective of genetic architecture, without specifying a 
heritability model or partitioning SNPs by allele frequency and/or LD. We show analytically and 
through extensive simulations starting from real genotypes (UK Biobank, N = 337K) that, unlike 
existing methods, our closed-form estimator is robust across a wide range of architectures. We 
provide estimates of SNP-heritability for 22 complex traits in the UK Biobank and show that, 
consistent with our results in simulations, existing biobank-scale methods yield estimates up to 
30% different from our theoretically-justified approach.
Editorial Summary:
The authors use theoretical justifications coupled with extensive simulations to accurately estimate 
SNP-heritability for 22 complex traits and diseases from the UK Biobank data irrespective of the 
underlying genetic architecture of the trait.
SNP-heritability, the proportion of phenotypic variance attributable to the additive effects of 
a given set of SNPs, is a fundamental quantity in genetics1; it provides an upper bound on 
risk prediction from a linear model2 and, when defined as a function of all SNPs on an array, 
yields insights into the “missing heritability” of complex traits3–5. Traditionally, SNP-
heritability is estimated by fitting variance components models with REML3,6–9. With some 
exceptions8, REML-based methods are not scalable to biobanks that assay hundreds of 
thousands of individuals (e.g., UK Biobank10). SNP-heritability can also be estimated by 
assessing the deviation in marginal association statistics as a function of LD scores11–14; 
such methods can scale to millions of individuals. More recently, a randomized extension of 
Haseman-Elston regression15 was shown to estimate a single genetic variance component 
from individual-level data as accurately as REML methods but in a fraction of the run-
time16.
To facilitate inference, all existing methods for genome-wide SNP-heritability inference 
make assumptions on genetic architecture, which is typically parametrized by polygenicity 
(the number of variants with effects larger than some small constant δ) and MAF/LD-
dependence (the coupling of effects with minor allele frequency (MAF), local linkage 
disequilibrium (LD), or other functional annotations)17. Since the true genetic architecture 
of any given trait is unknown, existing methods are susceptible to bias and often yield vastly 
different estimates even when applied to the same data9,14,18. Although multi-component 
methods that stratify SNPs by MAF/LD ameliorate some of these robustness issues7,18,19, 
fitting multiple variance components to biobank-scale data with REML is highly resource-
intensive8 and it is unclear whether multi-component methods based on summary statistics 
produce accurate estimates of total SNP-heritability. Alternate methods that explicitly model 
MAF/LD-dependency6,9,14 are also sensitive to model misspecification6,9,14,18,19. In 
addition, genetic architecture varies across traits and populations due to, for example, 
variable degrees of negative selection acting on different traits in different 
populations17,20–25. Methods that jointly infer SNP-heritability and parameters such as the 
strength of negative selection or polygenicity14,23,26 are computationally intensive and/or 
sensitive to LD-dependency. Thus, it remains unclear which estimates of SNP-heritability 
computed from biobank-scale data are reliable.
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In this work, we investigate whether genome-wide SNP-heritability can be accurately 
estimated under a generalized random effects (GRE) model that makes minimal assumptions 
on genetic architecture. Under this model, every causal effect has an arbitrary SNP-specific 
variance, and SNP-heritability is defined as the sum of the SNP-specific variances 
(Methods). To the best of our knowledge, all existing methods make additional assumptions 
on top of the GRE model (Table 1). For example, GREML3 (and several other 
methods8,16,27) imposes an inverse relationship between MAF and allelic effect size whereas 
LDAK assumes that each SNP-specific variance is inversely proportional to both MAF and 
LD tagging6,9. We derive a closed-form estimator for SNP-heritability as a function of 
marginal association statistics and in-sample LD and show that this estimator is consistent 
(approaches the true SNP-heritability as sample size increases) and unbiased (its expectation 
is equal to the true SNP-heritability) when the number of individuals exceeds the number of 
SNPs. Most importantly, the accuracy of this estimator is invariant to genetic architecture. 
While the GRE estimator is similar in form to previously proposed “fixed effect 
estimators,”28,29 our approach differs from previous work in two main ways. First, SNP-
heritability defined under a fixed effect model is different from the estimand of interest here 
(Methods). Second, previous work applied the estimator locally to identify regions 
contributing disproportionately to the genome-wide signal28,29; here we define a different 
genome-wide estimator (Equation 1) that requires large-scale genotype data. In addition, 
previous work applied an SVD-based regularization to account for errors in LD estimation 
from reference panels29 which was unnecessary in this work (Methods).
Through extensive simulations across a range of MAF/LD-dependent architectures starting 
from real genotypes from the UK Biobank10 (337K individuals, 593K SNPs), we find that 
the GRE estimator is nearly unbiased across all architectures whereas existing methods are 
sensitive to model misspecification. For example, across 126 distinct architectures, the 
maximum bias of the GRE estimator is 2% of the simulated SNP-heritability whereas 
stratified LD score regression (S-LDSC)12,13 and SumHer14 yield biases between −64% and 
28%. For completeness, we also contrast the GRE estimator with several REML-based 
methods in simulations at lower sample sizes (due to the computational burden of most 
REML methods) and find that, consistent with recent reports18, all REML-based methods 
are biased when their model assumptions are violated, and multi-component REML methods 
that stratify SNPs by MAF and LD score (GREML-LDMS-I18) are more accurate than 
single-component REML methods. The performance of the GRE estimator is similar to that 
of GREML-LDMS-I, thereby confirming that SNP-heritability can be accurately estimated 
without stratifying SNPs or specifying a heritability model6,9,14.
Finally, we use marginal association statistics and in-sample LD from 290K unrelated 
British individuals and 460K SNPs (MAF > 1%) to estimate SNP-heritability for 22 
complex traits in the UK Biobank10. Consistent with simulations, estimates from S-LDSC 
and SumHer differ from the GRE estimates by a median of −9% and 11%, respectively, 
across the 18 traits with SNP-heritability estimates exceeding 0.05. For example, for height, 
estimates from S-LDSC (0.56) and SumHer (0.63) are approximately 7% lower and 5% 
higher, respectively, than our estimate of 0.60. Similarly, for hypertension, estimates from S-
LDSC (0.14) and SumHer (0.18) are ±12.5% different from our estimate of 0.16. Taken 
together, our results demonstrate that SNP-heritability can be accurately estimated from 
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biobank-scale data without prior knowledge of the genetic architecture the trait, motivating 
the development of scalable methods with fewer modeling assumptions.
Results
Overview of the approach
We investigate the utility of an estimator derived under a model that makes minimal 
assumptions on genetic architecture. We model the standardized phenotype of an individual 
as y = xTβ + ϵ where x is an M-vector of standardized genotypes, β is the corresponding 
vector of standardized effects, and ϵ ∼ N 0, σe
2
 is environmental noise (Methods). The effect 
size of each SNP is assumed to have mean zero and a finite SNP-specific variance (σi2 for 
SNP i) that is allowed to be 0; the covariance between all pairs of effects is assumed to be 
zero. We term this model the “generalized random effects” (GRE) model as, to the best of 
our knowledge, all existing methods impose additional assumptions on top of this model. 
For example, the single-component GREML model3 assumes σi
2 = hg
2/M for i = 1,…,M
whereas the most recent LDAK model9 assumes σi
2 ∝ wi[ f i 1 − f i ]
0.75
 (where wi is a SNP-
specific LD weight and f i is MAF) (Table 1). Under the GRE model, the SNP-heritability 
explained by the M SNPs is the sum of the SNP-specific variances: 
hg
2 ≡ Var xTβ /Var y = ∑i = 1
M σi
2
 (Methods).
Given genotype measurements across N individuals at M SNPs and assuming N > M, the 
estimator hg
2 = Nβ
TV†β − q
N − q , where β is the vector of estimated marginal effects, V
†
 is the 
pseudoinverse of the in-sample LD matrix, and q is the rank of the in-sample LD, is an 
unbiased estimator of SNP-heritability under the GRE model. That is, E hg
2 = ∑i = 1
M σi
2 = hg
2
(Methods). Unfortunately, even the largest biobanks currently have N < M (i.e. UK Biobank 
has genotyped M ≈ 593K SNPs in N ≈ 337K unrelated British individuals), which limits the 
utility of the above estimator. We therefore extend our approach by partitioning the genome 
by chromosome:
hGRE
2 =
k = 1
22 Nβk
TVk
†βk − qk
N − qk
#(1)
where for chromosome k with pk SNPs, βk is the pk − vector of estimated effects, Vk
†
 is the 
pseudoinverse of the in-sample LD matrix, and qk is the rank of the in-sample LD. Although 
this estimator introduces bias, we show through extensive simulations that the magnitude of 
the bias is extremely small when N is sufficiently larger than pk.
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The GRE estimator is robust in simulations
To investigate the bias and variance of hGRE
2
, we perform simulations starting from real 
genotypes (N = 337205, UK Biobank10). First, we simulate 64 MAF/LD-dependent 
quantitative trait architectures from chromosome 22 M = 9654 typed SNPs) by varying the 
SNP-heritability hg
2
, proportion of causal variants pcausal , distribution of causal variant 
MAF (CV MAF), and strength of coupling between effect size and MAF/LD; we use 
“LDAK-LD-dependent” to describe causal effects that are coupled with “LDAK weights” 
(Methods). To compare estimates across different values of hg2, we assess bias as a 
percentage of the simulated value of hg
2
 (relative bias). Errors of individual estimates are also 
expressed as percentages of hg
2
. Consistent with analytical derivations, the GRE estimator 
restricted to chromosome 22 is unbiased across the 64 architectures (bias p-value < 0.05/16 
is considered significant in order to correct for 16 tests (architectures) at each value of hg2; 
Methods) (Figure 1ac, Supplementary Table 1). The average relative bias across the 64 
architectures is 0.00015% × hg
2
 and the largest bias under any single architecture is ±0.2% × hg
2
(Supplementary Figure 1a, Supplementary Table 1). In simulations of unascertained case-
control studies (Methods), the GRE estimator is approximately unbiased across a range of 
disease prevalences (for hg2 = 0.10, relative bias range is [−0.20%, 0.30%]) and has larger 
variance for lower prevalences (Supplementary Figure 2a, Supplementary Table 2). For 
ascertained case-control studies, estimates are downward-biased but invariant to architecture 
(when hg2 = 0.10, prevalence = 0.10, and Ncase = Ncontrol, relative bias is approximately −4%) 
(Supplementary Table 3). Masking 0%, 50%, or 100% of causal SNPs from the observed 
summary statistics induces downward-bias when CV MAF = [0.01, 0.05] due to lower 
average LD between the observed SNPs and masked causal SNPs (Supplementary Figure 3). 
The analytical estimator of the standard error (Methods) is well-calibrated (Supplementary 
Figure 4a, Supplementary Table 4). As expected, partitioning chromosome 22 into disjoint, 
non-independent blocks induces upward bias that increases as block size decreases 
(Supplementary Figure 5, Supplementary Table 5).
Next, we perform genome-wide simulations N = 337K individuals, M = 593K SNPs) to 
assess hGRE
2
 with the 22-block approximation (Equation 1). Despite the approximation, 
hGRE
2
 is highly accurate and robust across all 64 MAF- and LDAK-LD-dependent 
quantitative trait architectures (Figure 1b, 1c). Across the 64 architectures, the bias ranges 
from 0.07% to 2.1% × hg
2
 average = 0.97% × hg
2
 (Supplementary Figure 1b, Supplementary 
Table 6). Across all 6400 simulations (64 genetic architectures × 100 simulation replicates), 
the largest error of any single estimate is approximately 17% × hg
2
 (Figure 1c). As N /M
increases, the variance of hGRE
2
 decreases while the relative bias appears to be approximately 
fixed, ranging between 0.91% N = 100K  and 0.99% N = 200K  (Figure 1d). These trends 
hold for a range of pcausal (Supplementary Figure 6, Supplementary Table 6), for 
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unascertained case-control studies (Supplementary Figure 2b, Supplementary Table 7), and 
in a smaller set of simulations with N = 7685 individuals of South Asian ancestry and 
M = 1642 SNPs (Supplementary Table 8; Methods). Most importantly, the accuracy of the 
GRE estimator is invariant to the underlying architecture (Figure 1b). The analytical 
estimator for the standard error is downward-biased (and invariant to genetic architecture) 
with respect to the empirical standard deviation of hGRE
2
 estimates (Supplementary Figure 
4b, Supplementary Table 9). For example, across 16 architectures where hg2 = 0.25, the 
empirical standard deviation of 100 independent estimates ranges from 0.0049 to 0.0064, 
whereas our estimated standard errors are approximately 0.0036 across all architectures 
(Supplementary Figure 4b, Supplementary Table 9).
We investigate the effects of unmodeled substructure and/or cryptic relatedness by filtering 
individuals at different kinship coefficient thresholds (Methods) and find that using stricter 
relatedness thresholds increases the variance of the estimates (due to smaller sample size) 
while reducing bias, albeit not significantly (Supplementary Figure 7, Supplementary Table 
10). To assess the impact of population stratification, we simulated an effect of the first 
genetic principal component (PC) on phenotype and computed OLS association statistics 
both with and without adjusting for the first PC (Methods). As expected, OLS without PC 
adjustment yields inflated estimates while OLS with PC adjustment yields approximately 
unbiased estimates (Supplementary Figure 8, Supplementary Table 11). However, even when 
a relatively large proportion of phenotypic variance is explained by the first PC (e.g., 
hg
2 = 0.25, σs
2 = 0.05), the maximum bias we observe using unadjusted association statistics is 
5% × hg
2
 (bias p‐value = 2.7 × 10−9). Together, these results indicate that the GRE estimator is 
robust to modest amounts of unmodeled substructure and/or stratification. In all subsequent 
analyses, we compute hGRE
2
 with the 22-block approximation as this provides sufficiently 
accurate estimates and a fair comparison to other methods.
Comparison of methods to estimate SNP-heritability
We compare hGRE
2
 with existing state-of-the-art methods that are easily scalable to the full 
UK Biobank data N = 337K : LD score regression (LDSC), which assumes α = − 1 and no 
coupling of effects with LD11; stratified LD score regression (S-LDSC), which partitions hg2
by a set of annotations of interest12,13; and SumHer, a scalable extension of LDAK which 
explicitly models MAF/LD-dependency through a specific form of the SNP-specific 
variances14 (Table 1). To ensure a fair comparison, LD scores for all methods are computed 
using in-sample LD among the M SNPs, and in all simulations we aim to estimate the SNP-
heritability explained by the same M SNPs (Methods).
As expected, hGRE
2
 is robust across all architectures while LDSC, S-LDSC, and SumHer are 
sensitive to model misspecification. For example, when hg
2 = 0.25 (Figure 2), LDSC is 
approximately unbiased under the “single-component GREML model” (relative bias = 0.04%, 
p = 0.86) but is sensitive to CV MAF and the degree of coupling between effect size and 
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MAF/LD (e.g., when pcausal = 1%, relative bias ranges from −44% to 50%) (Supplementary 
Table 12). Similarly, SumHer is accurate under the “LDAK model” (relative bias = 5.3%)but 
highly sensitive to other architectures (when pcausal = 1%, relative bias ranges from −19% to 
22%) (Figure 2, Supplementary Table 13). S-LDSC (MAF), which partitions hg2 by 10 MAF 
bins (Supplementary Table 14; Methods), is less biased than LDSC when effects are coupled 
with only MAF, but is significantly downward-biased when effects are also coupled with 
LDAK weights (for hg2 = 0.25, relative bias range is [1.9%, 7.0%] when γ = 0 and [−58%, 
−37%] when γ = 1) (Figure 2, Supplementary Table 15). S-LDSC with 10 MAF bins and an 
additional “level of LD” annotation, denoted S-LDSC (MAF+LLD) (Methods), produces 
similar results (for hg2 = 0.25, relative bias range is [1.8%, 6.5%] when γ = 0 and [−80%, 
−33%] when γ = 1) (Supplementary Table 16). In contrast, the relative bias of hGRE
2
 ranges 
from 0.45% to 1.3% across the same 16 architectures where hg
2 = 0.25 and pcausal = 1%
(Figure 2, Supplementary Table 6). These trends hold for a range of hg2 and pcausal: across 
112 LDAK-LD- and/or MAF-dependent architectures, the average and range of the relative 
bias of each method are 0.96% [−0.06%, 2.1%] (GRE), −2.2% [−71%, 70%] (LDSC), −22% 
[−62%, 8.7%] (S-LDSC (MAF)), −29% [−89%, 9.0%] (S-LDSC (MAF+LLD)), and 2.8% 
[−27%, 28%] (SumHer) (Figure 1b, Figure 2, Supplementary Figures 9–12, Supplementary 
Tables 6,12,13,15,16). Across 14 alternative LD-dependent architectures where SNP-
specific variances are coupled with inverse LD scores instead of LDAK weights (“LD-score-
dependent” architectures; Methods, Supplementary Figure 13), hGRE
2
 remains nearly 
unbiased (relative bias range [0.52%, 1.3%]) whereas S-LDSC (MAF), S-LDSC (MAF
+LLD), and SumHer are generally downward-biased (Supplementary Figure 14, 
Supplementary Table 17).
For completeness, we compare to four widely used REML-based methods: GREML, which 
assumes α = − 1 and no coupling of effects with LD3; GREML-LDMS-I, a multi-
component extension of GREML that partitions SNPs by MAF and LD score18; BOLT-
REML, a computationally efficient variance components estimation method with 
assumptions similar to those of GREML8; and LDAK, which assumes a specific form of the 
SNP-specific LD weights and recommends setting α = − 0.25 6,9 (Table 1). Because it is 
computationally intractable to apply the REML-based methods to thousands of genome-
wide simulations with 337K individuals, we perform simulations using a reduced number of 
individuals N = 8430  and SNPs M = 14821  (Methods). As expected, the single-component 
methods (GREML, BOLT-REML, and LDAK) are sensitive to MAF/LD-dependency 
whereas the GRE estimator is robust across all architectures. For example, when hg
2 = 0.25
(Figure 3), GREML and BOLT-REML are accurate under the GREML model (GREML: 
relative bias = − 1.4%, p = 6.0 × 10−3, Supplementary Table 18; BOLT-REML: 
relative bias = − 0.16%, p = 0.75, Supplementary Table 19) and LDAK is approximately 
unbiased under the LDAK model (relative bias = 0.16%, p = 0.77, Supplementary Table 20), 
but all three are sensitive to CV MAF, α and γ. Across 12 architectures where pcausal = 1%
Hou et al. Page 7
Nat Genet. Author manuscript; available in PMC 2020 January 29.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(Figure 3), the relative biases are within [−15%, 7.9%] (GREML), [−14%, 9.1%] (BOLT-
REML), and [−34%, 8.2%] (LDAK) (Supplementary Tables 18–20). In contrast, for the 
same 12 architectures, hGRE
2
 yields relative biases in the range [−2.1%, 1.7%], which is 
comparable to the relative bias of GREML-LDMS-I (range [−2.9%, 1.5%]) using 8 GRMs 
(4 LD quartiles × 2 MAF bins) that align with CV MAF (Figure 3, Supplementary Tables 
21, 22). These trends hold over a range of hg2 and pcausal: across 112 LDAK-LD- and/or 
MAF-dependent architectures (Supplementary Figures 15–19), the average and range of the 
relative bias are 0.09% [−4.9%, 6.4%] (GRE), −0.6% [−5.9%, 2.3%] (GREML-LDMS-I), 
−2.9% [−27%, 15%] (GREML), −1.8% [−25%, 18%] (BOLT-REML), and −8.2% [−44%, 
13%] (LDAK) (Supplementary Tables 18–22). Similar trends are observed for LD-score-
dependent architectures (Supplementary Figure 20, Supplementary Table 23). In an extreme 
example where CV MAF is tightly concentrated near 1%, GREML-LDMS-I with the same 8 
GRMs as before is downward-biased whereas the GRE estimator remains robust 
(Supplementary Figure 21, Supplementary Tables 18–22). While the variance of our 
estimator is larger than the variances of the REML-based methods (Figure 3), our approach 
is designed for sample sizes several orders of magnitude larger than what we used in these 
simulations. In summary, our results confirm that it is possible to accurately estimate hg
2
under the GRE model.
SNP-heritability of 22 complex traits in the UK Biobank
Finally, we compute hGRE
2
 for 22 complex traits in the UK Biobank (290K unrelated British 
individuals, 460K SNPs; Methods)10. For comparison, we also provide estimates from 
LDSC, S-LDSC (controlling for the baseline-LD model13,30), and SumHer. Of the 22 traits 
analyzed (6 quantitative, 16 binary), we focus on 18 traits for which hGRE
2 > 0.05 (Table 2). 
For the 6 quantitative traits, hGRE
2
 ranges from 0.12 (smoking status) to 0.60 (height). Across 
the 12 binary traits, hGRE
2
 ranges from 0.064 (autoimmune disorders) to 0.16 (hypertension) 
(Table 2). These estimates are robust to filtering of individuals based on relatedness 
(Supplementary Table 24). We also computed hGRE
2
 from two additional sets of SNPs (MAF 
> 0.1% and MAF > 0.01%) and found that the estimates increase slightly for lower MAF 
thresholds (Supplementary Table 25), which is expected due to the increased number of 
SNPs. To enable a direct comparison between hGRE
2
 and the quantities estimated by LDSC, 
S-LDSC, and SumHer, we run the summary-statistics-based methods with LD scores and 
regression weights computed from in-sample LD and estimate hg
2
 defined as a function of the 
same set of SNPs (Methods). Across the 18 traits, S-LDSC (baseline-LD/in-sample) and 
SumHer (in-sample) differ from hGRE
2
 by a median of −9% and 11%, respectively (expressed 
as a percentage of hGRE
2 ) (Figure 4, Table 2). As expected11, LDSC (in-sample) yields 
inflated estimates.
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To compare hGRE
2
 to estimates reported in the literature, we also run the summary-statistics 
methods with their recommended parameter settings11,12,14,30 and with LD scores and 
regression weights computed from the 1000 Genomes Phase 3 reference panel (489 
Europeans)31 – we note that when running these methods as recommended, their estimands 
are not equivalent to our definition of hg
2
 (see Methods and refs.11,12,14,19 for details). Across 
the 18 traits for which hGRE
2 > 0.05, the median differences with respect to hGRE
2
 are −11% 
for LDSC (1KG), −14% for S-LDSC (baseline-LD/1KG), and 38% for SumHer (1KG) 
(Supplementary Figure 22, Supplementary Table 26). For 9 of these traits, a previous study 
reported single-component BOLT-REML estimates (computed from a similar UK Biobank 
cohort27) that differ from our estimates by a median of 8% (Supplementary Table 26).
Runtime and memory requirement
We report the runtime and memory requirements for computing hGRE
2
 with the 22-block 
approximation from 337K individuals and 593K SNPs. First, computing chromosome-wide 
LD has complexity O Npk
2
 for chromosome k with pk SNPs. In practice, this step does not 
impose a computational bottleneck because the computations can be parallelized over SNPs. 
Second, the pseudoinverse of each LD matrix is computed via truncated SVD, which has 
complexity O pk
3
 for chromosome k. For 50K typed SNPs this takes about 3 hours and 
60GB of memory. Lastly, given the pseudoinverse LD matrices and OLS association 
statistics, computing hGRE
2
 has complexity O p1
2 +⋯+ p22
2
 For any of the traits analyzed in 
this work, this takes less than 1 hour and requires 24GB of memory; most of this time is 
spent loading the data into memory. For comparison, running LDSC, S-LDSC, or SumHer 
consists of precomputing LD scores and SNP-specific weights and performing linear 
regression to estimate the variance parameters. Precomputing LD scores and SNP-specific 
weights can be parallelized over blocks of SNPs. The second step (least squares regression) 
is O C2M  for M SNPs in the regression and C variance parameters.
Discussion
In this work, we show that SNP-heritability can be accurately estimated under minimal 
assumptions on genetic architecture. Our proposed estimator allows the SNP-specific 
variances to capture arbitrary relationships between effect size and MAF/LD, and we 
demonstrate through simulations that its accuracy is invariant to genetic architecture. We 
show that all existing methods impose additional assumptions on the GRE model, and we 
confirm through simulations that these methods can be sensitive to model misspecification. 
One practical advantage of our approach over summary-statistics methods is that the 
estimand of our approach is always the same for a given genotype matrix, whereas the 
definitions and interpretations of the estimands of LDSC, S-LDSC, and SumHer depend on 
which SNPs are used in each step of inference (e.g., the SNPs used to compute LD scores 
need not be the same SNPs defining the estimand)11,12,19. Overall, our results show that 
while existing methods can yield biases, for the purpose of estimating total SNP-heritability, 
most methods are relatively robust.
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We conclude with several caveats and future directions. First, the utility of hGRE
2
 critically 
depends on the ratio between the number of SNPs (M) and the number of individuals (N) – 
as M /N increases, the eigenstructure of the in-sample LD matrix becomes increasingly 
distorted (larger eigenvalues are overestimated; smaller eigenvalues are underestimated)32. 
We mitigate this by assuming that chromosomes are approximately independent; as long as 
N exceeds the number of array SNPs per chromosome, hGRE
2
 provides meaningful estimates 
of SNP-heritability. While the utility of our approach is limited by the availability of 
individual-level biobank-scale data, this concern will abate as more biobanks are 
established33–35. A major limitation remains with respect to imputed/sequencing data as M 
will continue to be orders of magnitude larger than N for the foreseeable future. We defer an 
investigation of regularized estimation of LD in high-dimensional settings M > N  to future 
work.
Second, the theoretical guarantees of hGRE
2
 rely on the assumption that OLS association 
statistics and LD are estimated from the same genotypes. While summary statistics have 
been made publicly available for hundreds of large-scale GWAS, in-sample LD is usually 
unavailable for these studies since most are meta-analyses36. In addition, summary statistics 
are often computed using linear mixed models to control for confounding, and previous 
works have noted that the LD computation must be adjusted to accommodate mixed model 
association statistics36,37. Thus, the sensitivity of hGRE
2
 to reference panel LD (with or 
without regularized LD estimation) and/or mixed model association statistics remains 
unclear29,38. Furthermore, we simulate phenotypes from typed SNPs because imputed 
genotypes have highly irregular LD patterns9,18. Although it would be more realistic to 
simulate from sequencing data18, our simulation design required individual-level genotype 
measurements in biobank-scale sample sizes.
Third, hGRE
2
 does not correct for population structure/stratification. In real data, we mitigate 
this by considering only unrelated individuals (> 3rd degree relatives) and including age, 
sex, and the top 20 PCs as covariates when computing association statistics. While recent 
work has found evidence of assortative mating for some traits in the UK Biobank (e.g., 
height)39, our estimates are robust to different relatedness thresholds, suggesting that 
adjusting for the top 20 PCs sufficiently controls for population stratification. Still, it 
remains unclear how to quantify the bias of our genome-wide estimator due to structure or 
assortative mating in real data. Future work is needed to extend the GRE approach to control 
for ascertainment bias15,16,40,41.
Finally, while previous works applied similar estimators (defined under fixed effects models) 
to estimate local SNP-heritability within small regions28,29, additional work is needed to 
extend our approach to perform partitioning of SNP-heritability by functional annotations. 
Existing methods for partitioning SNP-heritability make various assumptions on genetic 
architecture8,12–14,30, motivating the development of new methods in this area.
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Methods
The generalized random effects model
We model the phenotype for an individual n randomly sampled from the population as 
yn = xn
Tβ + ϵn, where xn = xn1…xnM
T
 is a vector of standardized genotypes measured at M 
SNPs for individual n, β = β1, …, βM
T
 is an M-vector of the corresponding standardized 
SNP effects, and ϵn ∼ N 0, σe
2
 is environmental noise. We assume Var yn = 1 and that the 
genotype at each SNP i is centered and scaled in the population such that E xni = 0 and 
Var xni = 1; i.e. xni = gni − 2 f i / 2 f i 1 − f i , where gni ∈ 0, 1, 2  is the number of copies of 
the effect allele at SNP i for individual n, and f i is the population frequency of the effect 
allele at SNP i. We define the population LD between two SNPs i and j to be vi j ≡ E xnixn j
for all i ≠ j. The population LD matrix among the M SNPs is therefore V ≡ Cov xn
T
. For 
simplicity, we use “SNP effects” in lieu of “standardized SNP effects” to refer to β. We 
assume that xn and β are independent given allele frequencies f 1, …, fM  and V.
Under the generalized random effects (GRE) model, the first two moments of βi are E βi = 0
and Var βi = σi
2
, where σi
2
 can be any arbitrary nonnegative finite number. We assume the 
covariance between the effects of different SNPs is 0 (i.e. Cov βi, β j = E βiβ j = 0 for all 
i≠j). Because the SNP-specific variances can capture any degree of polygenicity and any 
relationship between genomic features (e.g., MAF and LD) and effect size, the GRE model 
encompasses most realistic genetic architectures (Table 1).
We define total SNP-heritability hg
2
 to be the proportion of phenotypic variance attributable 
to the additive effects of a set of M SNPs whose genotypes are directly measured:
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hg
2 ≡
Var xnTβ
Var yn
= E Var xnTβ β] + Var E xnTβ β ]
= E βTVar xnT β + Var E xnT β
= E βTVβ + 0
= E tr VββT
= tr VE ββT
hg
2 =
i = 1
M
σi
2
#(2)
Thus, hg
2
 is defined with respect to a given population and a given set of SNPs. By definition, 
0 ≤ hg
2 ≤ 1 Similarly, we define regional SNP-heritability hk
2
 to be the proportion of 
phenotypic variance due to the additive effects of the genotyped SNPs in region k We 
assume that the set of SNPs that defines hk
2
 is a subset of the M SNPs that define hg
2
 (thus, 
0 ≤ hk
2 ≤ hg
2). If region k is the whole genome, hk2 = hg2.
Estimating SNP-heritability under the GRE model
We are interested in estimating hg
2
 under the GRE model (Equation 2). In a GWAS with N
individuals genotyped at M SNPs, let X = x1
T,…, xN
T T
 be the N ×M matrix of standardized 
genotypes (each column of X has been standardized to have mean 0 and variance 1), 
y = y1,…, yN
T
 be the N-vector of standardized phenotypes, and V = 1/N XTX be the M ×M
in-sample LD matrix (an estimate of population LD, V) with rank q, where 1 ≤ q ≤ M. Let 
X = X1,…, XK  be the genotype matrices for K independent regions spanning all M SNPs 
(e.g., chromosomes). For region k containing pk SNPs, Xk is the N × pk standardized 
genotype matrix and Vk is the corresponding pk × pk in-sample LD matrix with rank qk
1 ≤ qk ≤ pk . We propose the following estimator for genome-wide SNP-heritability:
hGRE
2 =
k = 1
K Nβk
TVk
†βk − qk
N − qk
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where βk = 1/N Xk
Ty is the pk-vector of marginal SNP effects estimated by ordinary least 
squares (OLS) for region k and Vk
†
 is the pseudoinverse of Vk. Detailed derivations for hGRE
2
can be found in the Supplementary Note.
Analytical variance of hGRE
2
—Following quadratic form theory29,44, the variance of 
hGRE
2
 in the single-block case is
Var hGRE
2 = NN − q
2
2q
1 − hg
2
N + 4hg
2 1 − hg
2
N #(3)
When using the K-block approximation, which assumes that the blocks are independent, we 
approximate Equation 3 as the sum of the variances of the local SNP-heritabilities:
Var hGRE
2 =
k = 1
K
N
N − qk
2
2qk
1 − hk
2
N + 4hk
2 1 − hk
2
N #(4)
Equation 3 is estimated by plugging in hGRE
2
 and Equation 4 is estimated by plugging in 
h1
2,…, hK
2
, the estimates of the regional SNP-heritabilities.
Simulation Framework
We simulated quantitative phenotypes from real genotype array data (UK Biobank10) under 
a range of genetic architectures. We obtained a set of N = 337205 unrelated British 
individuals by extracting individuals with self-reported British ancestry who are > 3rd 
degree relatives (pairs of individuals with kinship coefficient < 1/2 9/2 10 and excluding 
individuals with putative sex chromosome aneuploidy. In all simulations, we standardize the 
genotypes before drawing phenotypes. That is, for each SNP i and individual n, we compute 
xni = gni − 2 f i / 2 f i 1 − f i  where gni ∈ 0, 1, 2  is the number of minor alleles and f i is the 
in-sample minor allele frequency (MAF).
Simulations of quantitative traits with no population stratification—Given X and 
a fixed value of hg
2
, phenotypes are drawn according to the following model. The proportion 
of causal variants, pcausal, is set to 1, 0.01, or 0.001. Let ci ∈ 0, 1  be the causal status of 
SNP i. If pcausal = 1, ci = 1 for i = 1,…, M. If 0 ≤ pcausal < 1, we draw pcausal ×M SNPs from 
the set of SNPs with MAF in one of three ranges: (0, 0.5], (0.01, 0.05], or (0.05, 0.5]. We 
use “CV MAF” to refer to the MAF range from which the causal variants are drawn. 
Standardized effects and phenotypes are then drawn according to the model
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σi
2 ∝ ci ⋅ wi
γ 2 f i 1 − f i
1 + α #(5)
β1,…, βk
T ∼ N 0, diag σ1
2,…, σM
2 #(6)
y1,…, yN
T β ∼ N Xβ, 1 − hg2 IN #(7)
where α controls the coupling of MAF and effect size, wi is a SNP-specific LD weight, and 
γ ∈ 0, 1  specifies whether effects are coupled with the LD weights. We simulate two types 
of LD-dependent architectures by defining w1,…,wM to be either (1) the default “LDAK 
weights” computed by the LDAK software6, or (2) the inverse unpartitioned “LD score” of 
each SNP computed within a 2-Mb window (wi−1 = ∑ jvi j2  where j indexes the set of SNPs 
within a 2-Mb window centered on SNP i)11. When γ = 1 both the LDAK weights and 
inverse LD score weights cause SNPs in regions of higher LD to have smaller effects than do 
SNPs in regions of lower LD. We set α to one of two values: α = − 1 (a relatively strong 
inverse relationship between MAF and effect size) or α = − 0.25 (a weaker inverse 
relationship between MAF and effect size). Each per-SNP variance is multiplied by a scaling 
factor so that ∑i = 1
M σi
2 = hg
2
. Note that σi
2 = 0 if ci = 0.
Finally, given phenotypes y = y1,…, yN
T
 and genotypes X = x1
T,…, xN
T T
, we compute 
marginal association statistics through ordinary least squares (OLS): β = 1/N XTy.
Simulations of case-control phenotypes with no population stratification—To 
simulate case-control studies, we first draw each individual’s continuous liability (ln for 
individual n) according to Equation 7. For a given population prevalence 0 ≤ dpop ≤ 1  we 
compute the corresponding liability threshold L = Φ−1 1 − dpop , where Φ is the CDF of the 
standard normal distribution. Each ln is then converted into a case-control status: yn = 1 if 
ln ≥ L or yn = 0 if ln < L. For unascertained case-control studies, we assume that the 
proportion of cases in the study is equal to the population prevalence dGWAS = dpop . For 
ascertained case-control studies dGWAS > dpop , we set dGWAS = 0.5 and select a random set 
of controls to satisfy Ncase = Ncontrol.
We compute association statistics by regressing the binary case-control statuses on 
genotypes. The GRE estimator produces an estimate of SNP-heritability on the observed 
scale hobs
2
. Assuming we know the population prevalence, we convert hobs
2
 to the liability 
Hou et al. Page 14
Nat Genet. Author manuscript; available in PMC 2020 January 29.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
scale with the transformation h liab
2 = hobs
2 dpop
2 1 − dpop
2/ f L 2dGWAS 1 − dGWAS , where 
f  is the standard normal probability density function45.
Simulations with population stratification—To simulate GWAS with population 
stratification, we draw phenotypes from a model where a covariate that is correlated to 
genotypes has a nonzero effect on phenotype. To this end, we simulate an effect of the first 
genetic principal component PC1 . Letting σs
2
 be the proportion of total phenotypic variance 
explained by PC1, phenotypes are drawn from the model
y1,…, yN
T β ∼ N Xβ + PC1βs, 1 − hg
2 − σs
2 IN
where Var PC1βs /Var y = βs
2Var PC1 = σs
2
. We compute association statistics from one of 
two models: y = XTβ + ϵ, which ignores population stratification and other sources of 
confounding, or y = XTβ + PC1βs + ϵ, which controls for the effect of PC1.
Comparison of methods in simulations
Unless otherwise specified, in all genome-wide simulations, we use real genotypes of N = 
337205 unrelated British individuals measured at M = 593300 array SNPs to draw causal 
effects for all M SNPs and phenotypes for all N individuals. OLS summary statistics are 
computed for all M SNPs using the simulated phenotypes and real genotypes of all N 
individuals. We compare to three methods that operate on summary statistics and are 
computationally tractable for these simulations: LD score regression (LDSC)11, stratified 
LD score regression (S-LDSC)12,13, and SumHer14.
For LDSC and S-LDSC, we compute the unpartitioned LD score of each SNP as a function 
of its LD to all other SNPs in a 2-Mb window centered on the SNP. For each annotation 
included in S-LDSC, the partitioned LD score of each SNP is a function of its LD to all 
SNPs within a 2-Mb window that are in the annotation. For both LDSC and S-LDSC, LD 
scores are computed with the LDSC software (https://github.com/bulik/ldsc/) from a random 
sample of 40K individuals to reduce the amount of memory required by the LDSC software. 
We run the regression with an unconstrained intercept, using all M SNPs as observations in 
the response variable. Each SNP is weighted to account for heteroscedasticity and 
correlations between association statistics11. For both methods, hg
2
 is estimated as a function 
of all M SNP-specific variances by using the flags --not-M-5–50 and --chisq-max 99999 (the 
latter option prevents the LDSC software from dropping high-effect SNPs).
We run S-LDSC in two ways to account for MAF/LD-dependent architectures. S-LDSC 
(MAF) refers to S-LDSC with 10 binary MAF bin annotations (each bin contains exactly 
10% of the typed SNPs), which is intended to mirror the 10 MAF annotations in the 
“baseline-LD model”13 (see Supplementary Table 14 for precise MAF bin ranges for the UK 
Biobank Axiom Array). S-LDSC (MAF+LLD) refers to S-LDSC with the same 10 MAF 
bins and an additional continuous “level of LD” (LLD) annotation computed by quantile-
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normalizing the unpartitioned LD scores within each MAF bin to a standard normal 
distribution13. While our definition of LLD is intended to mirror the LLD annotation in the 
baseline-LD model, we do not set the LLD of variants with MAF < 0.05 to 0 because our 
estimand of interest includes the effects of SNPs with MAF < 0.0513.
To run SumHer, we use the LDAK software (https://dougspeed.com/ldak/) to compute the 
default “LDAK weights” using in-sample LD6,9,14. We then compute “LD tagging” (i.e. LD 
scores) using 1-Mb windows centered on each SNP and setting α = − 0.25 as 
recommended14. The LDAK software is memory-efficient, allowing us to use all 337K 
individuals to compute LDAK weights and LD tagging. Unless otherwise specified, all 
default parameter settings are used to run SumHer in simulations.
We also perform simulations with N = 8430 unrelated individuals at M = 14821 array SNPs. 
These individuals and SNPs are a subset of the data used in the genome-wide simulations, 
chosen by selecting approximately 2.5% of individuals and the first 2.5% of SNPs from the 
beginning of each chromosome in order to preserve the LD structure among the SNPs. We 
run single-component GREML3,46 (GCTA software: https://cnsgenomics.com/software/
gcta/) and single-component BOLT-REML8 (https://data.broadinstitute.org/alkesgroup/
BOLT-LMM/) with default parameters. We run GREML-LDMS-I18,46 using 8 GRMs 
created from 2 MAF bins (MAF ≤ 0.05 and MAF > 0.05) and 4 LD score quartiles; LD 
scores were computed using the GCTA software with the default window size of 200-kb. We 
run LDAK using the default LDAK weights, setting α = − 0.25 as recommended6,9.
A third set of simulations was performed using 7,685 individuals of South Asian ancestry in 
the UK Biobank. This group was composed of individuals of Indian (n = 5,716), Pakistani (n 
= 1,748), and Bangladeshi (n = 221) ancestry. Due to the small sample size, we used a 
reduced set of 803 SNPs from chromosome 21 and 839 SNPs from chromosome 22 (1,642 
SNPs in total) which were chosen so that N /pk for each chromosome k was similar to N /pk
in the “white British” cohort.
For a given genetic architecture, we generate 100 simulation replicates and obtain 100 
estimates of hg
2
 from each method. We estimate the bias of an estimator hg
2
 under a given 
architecture as bias [hg
2] = E[hg
2] − hg
2 ≈ 1/100 ∑i = 1
100 hg
2 i − hg
2
 where hg
2 i  is the estimate 
from the i-th simulation. To test whether the bias is statistically significant (null hypothesis: 
bias [hg
2] = 0), we assess the z-score of the bias (zbias = bias[hg
2]/SEM[hg
2], where SEM[hg
2] is 
the standard error of the mean of the 100 estimates) which follows a N(0, 1  distribution 
under the null hypothesis. The p-value of the bias is computed with a two-tailed test. To 
enable a comparison of estimators across different values of hg
2
, we assess the relative bias of 
an estimator under a single architecture bias[hg
2]/hg
2) as a percentage of hg
2
. In Figure 1a and 
1c, we compute the error of a single estimate as (hg
2 i − hg
2)/hg
2; errors are also reported as 
percentages of hg
2
.
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Analysis of UK Biobank phenotypes
We estimate SNP-heritability for 22 complex traits (6 quantitative, 16 binary) in the UK 
Biobank10. We use PLINK47 (https://www.cog-genomics.org/plink2) to exclude SNPs with 
MAF < 0.01 and genotype missingness > 0.01 as well as SNPs that fail the Hardy-Weinberg 
test at significance threshold 10−7. We keep only the individuals with self-reported British 
white ancestry and no kinship (i.e. > 3rd degree relatives, defined as pairs of individuals with 
kinship coefficient < 1/2 9/2 )10. After removing individuals who are outliers for genotype 
heterozygosity and/or missingness, we obtain a set of N = 290,641 individuals to use in the 
real data analyses. For all traits, marginal association statistics are computed through OLS in 
PLINK, using age, sex, and the top 20 genetic principal components (PCs) as covariates in 
the regression; these 20 PCs were precomputed by UK Biobank from a superset of 488,295 
individuals. Additional covariates were used for waist-to-hip ratio (adjusted for BMI) and 
diastolic/systolic blood pressure (adjusted for cholesterol-lowering medication, blood 
pressure medication, insulin, hormone replacement therapy, and oral contraceptives). We 
compute hGRE
2
 for each trait using in-sample LD estimated from all N individuals.
When using LDSC, S-LDSC, or SumHer to estimate SNP-heritability, it is necessary to 
define and distinguish between the following sets of SNPs: the set of SNPs containing all 
possible causal SNPs of interest (used to compute LD scores and LDAK weights), the set of 
SNPs used as observations in the regression, and the set of SNPs that defines the SNP-
heritability estimand of interest. We run two versions of LDSC, S-LDSC (controlling for the 
most recent baseline-LD model12,13,30), and SumHer14. First, to enable a direct comparison 
between hGRE
2
 and the estimands of LDSC, S-LDSC, and SumHer, we run an “in-sample 
LD” version of each method where the M typed SNPs are used to compute LD scores and 
LDAK weights, perform the regression, and define the SNP-heritability estimand of interest. 
We refer to these as LDSC (in-sample), S-LDSC (baseline-LD/in-sample), and SumHer (in-
sample). To run LDSC (in-sample) and S-LDSC (baseline-LD/in-sample), we use the LDSC 
software to compute LD scores and regression weights within 2-Mb windows centered on 
each SNP, using a random sample of 40K individuals to reduce the memory requirement. To 
run SumHer (in-sample), we use the LDAK software to compute LD tagging from the 
genotypes of all N individuals, using 1-Mb windows centered on each SNP and setting 
α = − 0.25 as recommended9,14. Unless otherwise specified, all other parameters were set to 
the default settings.
To enable comparisons between hGRE
2
 and estimates reported in the literature, we also run 
each method with its recommended parameter settings and LD estimated from reference 
panel sequencing data. We refer to these methods as LDSC (1KG), S-LDSC (baseline-LD/
1KG), and SumHer (1KG) to indicate that LD is estimated from 489 Europeans in the 1000 
Genomes Phase 3 reference panel31. We run LDSC (1KG) and S-LDSC (baseline-LD/1KG) 
with LD scores and regression weights (1-cM windows) from 9,997,231 SNPs with minor 
allele count greater than 5 in the reference panel, and we define the SNP-heritability 
estimand to be a function of the array SNPs with MAF > 0.0511,12. We run SumHer (1KG) 
using 8,569,062 SNPs with MAF > 0.01 in the reference panel to compute LDAK weights 
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and LD tagging (1-cM windows) and to define the SNP-heritability estimand; we control for 
a multiplicative inflation of test statistics as recommended14. See refs.11,12,14,19 for details 
about the definitions and interpretations of the estimands of LDSC, S-LDSC, and SumHer.
Life Sciences Reporting Summary
Additional information on experimental design can be found in the Life Sciences Reporting 
Summary.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Simulations under 64 distinct MAF/LD-dependent architectures (N = 337205). For each 
value of hg
2
, phenotypes were drawn according to one of 16 genetic architectures defined by 
pcausal, CV MAF, α, and γ (Methods). (a) Distribution of errors hGRE
2 i − hg
2
 (as a percentage 
of hg
2), where hGRE
2 i  is the estimate from the i-th simulation under a given genetic 
architecture, in simulations on chromosome 22 (M = 9654 SNPs). hGRE
2
 was computed with 
1 chromosome-wide LD block. Black points and error bars represent the mean and ±2
standard errors of the mean (s.e.m.) which were used to test whether the bias under a single 
architecture is significant (Methods). (b) Distribution of hGRE
2
 in genome-wide simulations 
(M = 593300 SNPs) where hGRE
2
 was computed with 22 chromosome-wide LD blocks. In 
(a) and (b), each boxplot represents estimates from 100 simulations. Boxplot whiskers 
extend to the minimum and maximum estimates located within 1.5 × IQR from the first and 
third quartiles, respectively. (c) Distribution of errors for chromosome 22 and genome-wide 
simulations. Each violin plot represents the errors of 6400 estimates (64 genetic 
architectures × 100 simulation replicates). (d) Distribution of relative bias (as a percentage 
of hg
2) as a function of sample size (N = 100K, 200K, or 337K) in genome-wide simulations. 
Each violin plot represents 64 estimates of relative bias. In (c) and (d), the white diamonds 
mark the mean of each distribution.
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Figure 2. 
Comparison of hGRE
2
 with LDSC, S-LDSC (MAF), and SumHer in genome-wide 
simulations (N = 337205, M = 593300, hg2 = 0.25). Left: Phenotypes were drawn under one 
of 16 MAF- and/or LDAK-LD-dependent architectures by varying pcausal, α, γ, and CV 
MAF (Methods). Each boxplot contains estimates of hg2 from 100 simulations. Right: 
Relative bias of each method (as a percentage of hg2) across 112 distinct MAF- and LDAK-
LD-dependent architectures (Methods). Each boxplot contains 112 points; each point is the 
relative bias estimated from 100 simulations under a single genetic architecture. The white 
diamonds mark the average of each distribution. Boxplot whiskers extend to the minimum 
and maximum estimates located within 1.5 × IQR from the first and third quartiles, 
respectively.
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Figure 3. 
Comparison of hGRE
2
 with GREML, BOLT-REML, GREML-LDMS-I, and LDAK in small-
scale simulations (N = 8430, M = 14821 SNPs). Left: Phenotypes were drawn under one of 
16 MAF- and/or LDAK-LD-dependent architectures by varying pcausal, α, γ, and CV MAF 
(Methods). Each boxplot contains estimates of hg2 from 100 simulations. Right: Relative bias 
of each method (as a percentage of the true hg2) across 112 distinct MAF- and LDAK-LD-
dependent architectures (Methods). Each boxplot represents the distribution of 112 points; 
each point is the relative bias estimated from 100 simulations under a single genetic 
architecture. The white diamonds mark the average of each distribution. Boxplot whiskers 
extend to the minimum and maximum estimates located within 1.5 × IQR from the first and 
third quartiles, respectively.
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Figure 4. 
Percent difference of hg
2
 estimates from LDSC (in-sample), S-LDSC (baseline-LD/in-
sample), and SumHer (in-sample) with respect to hGRE
2
 for 18 complex traits and diseases in 
the UK Biobank for which hGRE
2 > 0.05 (N = 290K unrelated British individuals, M = 460K 
typed SNPs; Methods). Each bar represents the difference between the estimated hg2 from 
one of the methods (LDSC, S-LDSC, or SumHer) and hGRE
2
 as a percentage of hGRE
2
. Black 
bars mark ±2 standard errors.
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Table 1.
Existing methods to estimate SNP-heritability impose additional assumptions on top of the generalized 
random effects (GRE) model. Under the GRE model, the causal effects at any two SNPs are assumed to be 
independent (E[βiβ j] = 0 for all i ≠ j) and genome-wide SNP-heritability is defined as hg2 ≡ ∑i = 1M σi2, where 
each σi
2
 can be an arbitrary nonnegative real number as long as 0 ≤ hg
2 ≤ 1 (Methods). All existing methods 
make assumptions on the distribution of βi and/or the form of σi
2
 that can be subsumed under the GRE model. 
To simplify notation, we assume for each model that phenotypes are standardized in the population (i.e. 
Var yn = 1 for every individual n).
Model Assumptions on βi Description
Generalized 
random effects E βi = 0, Var βi = σi
2
, σi
2 ≥ 0
Each SNP i has a nonnegative SNP-specific variance σi
2
. Total SNP-
heritability is hg
2 ≡ ∑i = 1
M σi
2
.
GREML-SC 
3,8,16 βi ∼ N 0, hg
2/M Each SNP explains an equal portion of hg
2
. In other words, σi
2 = hg
2/M
for all i = 1,…,M.
GREML-MC 
7,8,18,42,43 βi ∼ N 0, ∑c ∈ C SNPi ∈ c hc
2/mc
hg
2
 is partitioned by a set of disjoint SNP partitions C that span all M
SNPs. Partition c ∈ C contains mc SNPs that have per-SNP variances 
hc
2/mc. Total SNP-heritability is hg
2 = ∑c ∈ Chc
2
.
LDAK6,9 βi ∼ N 0, σi
2
, σi
2 ∝ wi[ f i 1 − f i ]
1 + α
Each SNP-specific variance is proportional to a function of f i (the MAF 
of SNP i) and to wi (a SNP-specific weight that is a function of the 
inverse of the LD score of SNP i).α controls the relationship between σi
2
and f i. The most recent recommendation by ref.
9
 is to assume 
α = − 0.25.
LDSC11 E[βi] = 0, Var βi = hg
2/M
Each SNP explains an equal portion of hg
2
 (similar to the GREML-SC 
model when hg
2
 is defined with respect to the same set of M SNPs).
S-LDSC12,13,30 E[βi] = 0, Var[βi] = ∑a ∈ Aτaa i
Each SNP-specific variance is a linear function of a set of annotations A
where each a ∈ A represents a binary or continuous-valued annotation. 
a i  is the value of annotation a at SNP i. τa is the expected contribution 
of a one-unit increase in annotation a to each SNP-specific variance.
SumHer14 E[βi] = 0, Var βi ∝ wi f i 1 − f i
1 + α
An extension of the LDAK model to operate on summary-level data; can 
also efficiently partition hg
2
 by multiple annotations. The most recent 
recommendations by refs.9,14 is to set α = − 0.25.
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Table 2.
Estimates of hg
2
 from the GRE approach, LDSC (in-sample), S-LDSC (baseline-LD/in-sample), and SumHer 
(in-sample) for 22 complex traits and diseases in the UK Biobank (N = 290K unrelated British individuals, M 
= 460K typed SNPs).
Trait GRE S.E. LDSC S.E. S-LDSC S.E. SumHer S.E.
Smoking Status 0.122 3.90E-03 0.178 7.70E-03 0.110 8.50E-03 0.132 4.30E-03
Height 0.602 4.70E-03 0.730 2.70E-02 0.555 3.10E-02 0.634 2.70E-02
BMI 0.285 4.20E-03 0.436 1.20E-02 0.289 1.70E-02 0.315 9.00E-03
WHR 0.173 4.00E-03 0.256 1.20E-02 0.184 1.60E-02 0.198 9.40E-03
Systolic Blood Pressure 0.159 4.20E-03 0.243 9.00E-03 0.134 9.70E-03 0.177 5.70E-03
Diastolic Blood Pressure 0.154 4.20E-03 0.233 8.60E-03 0.130 9.70E-03 0.170 6.40E-03
Eczema 0.116 4.20E-03 0.165 1.10E-02 0.107 1.20E-02 0.130 8.80E-03
Asthma 0.116 4.90E-03 0.163 1.20E-02 0.116 1.70E-02 0.131 1.20E-02
Hypertension 0.162 4.00E-03 0.244 9.40E-03 0.142 1.10E-02 0.180 6.10E-03
High Cholesterol 0.082 5.10E-03 0.127 1.30E-02 0.138 5.80E-02 0.088 8.30E-03
Diabetes (Any) 0.070 3.70E-03 0.093 5.90E-03 0.062 8.70E-03 0.074 5.00E-03
Type 2 Diabetes 0.071 3.80E-03 0.090 6.10E-03 0.057 8.80E-03 0.071 4.00E-03
Hypothyroidism 0.088 5.20E-03 0.142 1.30E-02 0.078 1.20E-02 0.110 1.70E-02
Thyroid Disorders 0.084 5.20E-03 0.141 1.30E-02 0.080 1.20E-02 0.110 2.00E-02
Endocrinopathies 0.069 5.10E-03 0.084 7.00E-03 0.058 9.90E-03 0.068 5.00E-03
Cardiovascular Diseases 0.143 5.30E-03 0.228 1.10E-02 0.140 1.40E-02 0.164 6.00E-03
Respiratory and ENT Diseases 0.086 5.20E-03 0.120 1.20E-02 0.079 1.40E-02 0.090 9.50E-03
Psoriasis 0.019 5.00E-03 0.071 3.10E-02 0.035 1.20E-02 0.059 4.20E-02
Dermatologic Disorders 0.023 5.00E-03 0.049 1.40E-02 0.034 9.90E-03 0.031 1.10E-02
Rheumatoid Arthritis 0.008 5.00E-03 0.041 2.10E-02 0.010 7.90E-03 0.021 1.20E-02
Autoimmune Disorders (Broad) 0.063 5.10E-03 0.105 1.20E-02 0.050 9.50E-03 0.079 1.70E-02
Autoimmune Disorders (Certain) 0.015 5.00E-03 0.052 2.60E-02 0.005 7.60E-03 0.047 3.40E-02
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